Michael Tadross, MD, PhD, joined the department of Neurosurgery as an assistant professor on July 1, 2025.
Tadross is a scientist whose lab develops cell-type-specific neuropharmacology tools, notably DART (drug acutely restricted by tethering). These tools test how drugs work in the brain with the long-term goal of programmable, targeted neuropsychiatric therapies. The lab currently applies these methods to problems in Parkinson’s disease and addiction.
While Tadross is new to the faculty of Duke Neurosurgery, he joined Duke in July 2017 and has been an Assistant Professor in Neuroscience and Biomedical Engineering.
He earned his MD/PhD at Johns Hopkins and completed postdoctoral training at Stanford University. Tadross also launched an independent program as an HHMI Janelia Fellow.